Deadly listeria outbreak linked to chicken alfredo fettucine sold at Kroger and Walmart
On Jun. 18, 2025, federal health officials announced a listeria food poisoning outbreak that has killed three people…
-
-
Lilly to acquire Verve Therapeutics for $1 billion to advance one-time treatments for people with high cardiovascular risk
On Jun. 17, 2025, Eli Lilly and Verve Therapeutics, a Boston-based clinical-stage company developing genetic medicines for cardiovascular…
-
Scientists can now target the cells at the center of ALS
On Jun. 16, 2025, the Allen Institute announced that for the first time ever, scientists have developed a…
-
‘Artificial pancreas’ transforming the lives of thousands of children and young people with type 1 diabetes
On Jun. 16, 2025, the National Institute for Health and Care Excellence (NICE) announced that the recommendation in…
-
Biotechnology | Disease | Medicine | Oncology | Therapeutics
UK Nice leads the way in approving breakthrough treatment for multiple myeloma
On Jun. 13, 2025, people in England will become the first in the world to receive belantamab mafodotin…
-
Pioneering cancer plasticity atlas will help predict response to cancer therapies
On Jun. 12, 2025, the Wellcome Sanger Institute, Parse Biosciences and the Computational Health Center at Helmholtz Munich…
-
Scientists map the first step in Alzheimer’s protein aggregation and discover clues for future therapies
On Jun. 11, 2025, researchers from the Wellcome Sanger Institute, Centre of Genomic Regulation (CRG) and Institute for…
-
New therapeutic strategy help lower cholesterol levels by 50%
On Jun. 11, 2025, a study led by by University of Barcelona experts Carles J. Ciudad and Verònica…
-
Two patient cases of Legionella pneumonia reported
On Jun. 10, 2025, two patients treated within the past two months at the University of Washington Medical…
-
USC Dornsife study reveals how protein droplets help cells master difficult DNA repair
On Jun. 5, 2025, research from University of Southern California, Dornsife (USC Dornsife) scientists reveals how cells fix…
-
Emory study finds molecular link between air pollution and pregnancy risks
On Jun. 3, 2025, a study by Emory University researchers, published in Environmental Science & Technology, found that…
-
‘Definitive test’ finds exercise a potent weapon against colon cancer
On Jun. 2, 2025, a first-of-its-kind international trial provides definitive evidence that people who follow a structured exercise program…
-
Sanofi to acquire Blueprint Medicines for $9.1 Billion
On Jun. 2, 2025, Sanofi and Blueprint Medicines, a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis…
-
Common gene variant doubles dementia risk for men
On May 30, 2025, researchers from Curtin Medical School reported that they have found that men who carry…
-
Pfizer’s BRAFTOVI® Combination Regimen Cuts the Risk of Death in Half for Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer
On May 30, 2025, Pfizer announced statistically significant and clinically meaningful survival results from the Phase 3 BREAKWATER…
-
New technique expands cells to sequence DNA and capture fine structural details
On May 29, 2025, Broad Institute researchers announced they have developed a technology that provides new insight into…
-
CIRM awards $4.7 million for vision loss gene therapy
On May 29, 2025, The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
-
Scientists test real-time view of brain’s waste removal
On May 27, 2025, a research team from the University of Washington Medical Center and the University of…
-
Cardiology | COVID-19 | Disease | Environmental | Infectious Disease | Influenza | Measles | Oncology | Vaccine
U.S. excess deaths continued to rise even after the COVID-19 pandemic
On May 23, 2025, a Boston University School of Public Health (BUSPH) led study revealed that there were…
-
From Chaos to Clarity: New Tool Finds Connections in Complex Cell Data
On May 22, 2025, Gladstone scientists unveiled a powerful computation tool that integrates different forms of biological data…
-
Diagnostics | Disease | Infectious Disease | Medicine | Oncology | Rare Disease | Therapeutics | WHO
Global leaders reaffirm commitment to WHO with More Than US$ 170 million
On May 20, 2025, the World Health Organization (WHO) announced that world leaders pledged at least an additional…
-
New study aims to uncover the genetics of anorexia and other eating disorders
On May 19, 2025, researchers at the Broad Institute Ben Neale and Mark Daly are co-leading the study,…
-
Regeneron to Acquire 23andMe® for $256 Million
On May 19, 2025, Regeneron Pharmaceuticals announced it has been named the successful bidder in the bankruptcy auction…
-
Biotechnology | Diagnostics | Disease | Genomics | Oncology | Therapeutics
Jumping genes Alters the Genome
On May 19, 2025, researchers from the Karlsruhe Institute of Technology (KIT) announced they have have discovered how…
-
First human bladder transplant performed at UCLA
On May 18, 2025, a surgical team from the University of California, Los Angeles Health (UCLA Health) announced…
-
Biology | Diagnostics | Disease | FDA | Medical Device | Neurology | Therapeutics
FDA clears first blood test for Alzheimer’s detection
On May 16, 2025, the U.S. Food and Drug Administration has cleared Fujirebio Diagnostics’ blood test to diagnose…
-
Florida Becomes 2nd state to ban fluoride from its water system
On May 15, 2025, Florida Republican Gov. Ron DeSantis signed a measure prohibiting local governments from adding fluoride…
-
Disease | FDA | Neurology | Pharmaceutical | Therapeutics
Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for Acute Treatment of Migraine
On May 15, 2025, Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved Brekiya®…
-
Genetic Factors May Influence Liver Fat Even in Healthy Weight People
On May 15, 2025, researchers at the Translational Genomics Research Institute (TGen), part of City of Hope, announced…
-
Biotechnology | Disease | FDA | Oncology
US FDA approves AbbVie’s drug for a type of lung cancer
On May 14, 2025, The U.S. Food and Drug Administration (FDA) has approved AbbVie’s drug to treat adults…
